Publication | Open Access
Extracellular HMGB1 exacerbates autoimmune progression and recurrence of type 1 diabetes by impairing regulatory T cell stability
45
Citations
32
References
2020
Year
The present data support the possibility that HMGB1 could be a viable therapeutic target to prevent the initiation, progression and recurrence of autoimmunity in the setting of type 1 diabetes.
| Year | Citations | |
|---|---|---|
Page 1
Page 1